Geron (GERN) Interest & Investment Income (2010 - 2026)
Geron's (GERN) quarterly Interest & Investment Income came in at $3.4 million in Q1 2026, down 33.6% year-on-year from $5.2 million in Q1 2025, and down 15.43% quarter-over-quarter from $4.0 million in Q4 2025.
Geron (GERN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Geron has disclosed Interest & Investment Income across 17 years of filings, most recently posting $3.4 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $3.4 million, down 33.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.4 million (down 20.15% YoY), and the FY2025 annual result was $18.1 million, down 7.6% from the prior year.
- Interest & Investment Income came in at $3.4 million for Q1 2026 at Geron, down from $4.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q2 2024 to a low of $112000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $4.3 million (2025), against an average of $3.6 million.
- Across the five-year window, Interest & Investment Income sank 35.26% in 2022 and surged 3340.18% in 2023, its largest moves.
- Geron's Interest & Investment Income stood at $1.2 million in 2022, then surged by 272.15% to $4.6 million in 2023, then gained by 12.25% to $5.2 million in 2024, then slipped by 21.59% to $4.0 million in 2025, then retreated by 15.43% to $3.4 million in 2026.
- The last three Interest & Investment Income figures came in at $3.4 million (Q1 2026), $4.0 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.42 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Sep 30, 2025 | 4.26 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 5.15 Mn |
| Dec 31, 2024 | 5.16 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 5.33 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Mar 31, 2023 | 3.85 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 852,000.00 |
| Jun 30, 2022 | 330,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 106,000.00 |
| Sep 30, 2021 | 112,000.00 |
| Jun 30, 2021 | 136,000.00 |